Header Logo

Connection

ERICH M STURGIS to Head and Neck Neoplasms

Back to Details
This is a "connection" page, showing publications ERICH M STURGIS has written about Head and Neck Neoplasms.
ERICH M STURGIS
Connection Strength
8.576
Head and Neck Neoplasms
  1. Surviving Surveillance-Are Current Head and Neck Cancer Posttreatment Surveillance Recommendations Better for Patients or Ourselves? JAMA Otolaryngol Head Neck Surg. 2022 01 01; 148(1):51-52.
    View in: PubMed
    Score: 0.282
  2. Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma. Head Neck. 2020 09; 42(9):2440-2452.
    View in: PubMed
    Score: 0.252
  3. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50. Cancer. 2017 Oct 15; 123(20):3943-3954.
    View in: PubMed
    Score: 0.206
  4. International Head and Neck Cancer Epidemiology Consortium: Update no. 12. Head Neck. 2013 Oct; 35(10):1371-2.
    View in: PubMed
    Score: 0.159
  5. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer. 2013 Jul 15; 119(14):2593-601.
    View in: PubMed
    Score: 0.154
  6. International Head and Neck Cancer Epidemiology Consortium: update no. 9. Head Neck. 2013 Jan; 35(1):2-3.
    View in: PubMed
    Score: 0.150
  7. Neighborhood deprivation and clinical outcomes among head and neck cancer patients. Health Place. 2012 Jul; 18(4):861-8.
    View in: PubMed
    Score: 0.143
  8. Malignant fibrous histiocytoma of the head and neck region. Head Neck. 2011 Mar; 33(3):303-8.
    View in: PubMed
    Score: 0.133
  9. The International Head and Neck Cancer Epidemiology consortium. Head Neck. 2011 Jan; 33(1):141.
    View in: PubMed
    Score: 0.131
  10. Glutathione-S-transferase polymorphisms and complications of microvascular head and neck reconstruction. Arch Facial Plast Surg. 2010 Nov-Dec; 12(6):373-8.
    View in: PubMed
    Score: 0.130
  11. No evidence of sex-related survival disparities among head and neck cancer patients receiving similar multidisciplinary care: a matched-pair analysis. Clin Cancer Res. 2010 Oct 15; 16(20):5019-27.
    View in: PubMed
    Score: 0.129
  12. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila). 2009 Sep; 2(9):782-91.
    View in: PubMed
    Score: 0.120
  13. Liposarcoma of the head and neck: The University of Texas M. D. Anderson Cancer Center experience. Head Neck. 2009 Jan; 31(1):28-36.
    View in: PubMed
    Score: 0.114
  14. Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg. 2008 Feb; 121(2):451-457.
    View in: PubMed
    Score: 0.107
  15. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck. 2008 Jan; 30(1):75-84.
    View in: PubMed
    Score: 0.107
  16. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007 Oct 01; 110(7):1429-35.
    View in: PubMed
    Score: 0.105
  17. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension. Head Neck. 2007 Aug; 29(8):731-40.
    View in: PubMed
    Score: 0.104
  18. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck. 2007 Jul; 29(7):682-99.
    View in: PubMed
    Score: 0.103
  19. The role of human papillomavirus in squamous carcinoma of the head and neck. Curr Oncol Rep. 2006 Mar; 8(2):130-9.
    View in: PubMed
    Score: 0.094
  20. After the smoke clears: environmental and occupational risks for carcinoma of the upper aerodigestive tract. Cancer J. 2005 Mar-Apr; 11(2):96-103.
    View in: PubMed
    Score: 0.088
  21. Neurothekeoma. Otolaryngol Head Neck Surg. 2005 Jan; 132(1):86-9.
    View in: PubMed
    Score: 0.087
  22. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol. 2004 Dec; 31(6):726-33.
    View in: PubMed
    Score: 0.086
  23. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol. 2004 Oct 01; 22(19):3981-8.
    View in: PubMed
    Score: 0.085
  24. Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age. Arch Otolaryngol Head Neck Surg. 2004 Jul; 130(7):869-73.
    View in: PubMed
    Score: 0.084
  25. Cocaine use and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Med. 2024 Feb; 13(3):e7019.
    View in: PubMed
    Score: 0.081
  26. Outcomes of Head and Neck Microvascular Free Tissue Transfer for Advanced Cutaneous Squamous Cell Carcinoma: A Comparison of Solid Organ Transplant Recipients to Nontransplant Patients. J Oral Maxillofac Surg. 2024 Mar; 82(3):347-355.
    View in: PubMed
    Score: 0.080
  27. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6.
    View in: PubMed
    Score: 0.078
  28. Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy. Head Neck. 2023 Aug; 45(8):1943-1951.
    View in: PubMed
    Score: 0.078
  29. Sarcomas of the head and neck region. Curr Opin Oncol. 2003 May; 15(3):239-52.
    View in: PubMed
    Score: 0.077
  30. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2002 Sep; 128(9):1084-8.
    View in: PubMed
    Score: 0.074
  31. XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. Oral Oncol. 2002 Jul; 38(5):475-7.
    View in: PubMed
    Score: 0.073
  32. Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck. Int J Cancer. 2022 08 15; 151(4):553-564.
    View in: PubMed
    Score: 0.072
  33. Genetic susceptibility--molecular epidemiology of head and neck cancer. Curr Opin Oncol. 2002 May; 14(3):310-7.
    View in: PubMed
    Score: 0.072
  34. Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Sci Rep. 2022 04 22; 12(1):6662.
    View in: PubMed
    Score: 0.072
  35. Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression. Head Neck. 2022 07; 44(7):1520-1527.
    View in: PubMed
    Score: 0.072
  36. Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium. Oral Dis. 2023 May; 29(4):1565-1578.
    View in: PubMed
    Score: 0.072
  37. Detection accuracy of the Cobas HPV assay for high-risk HPV in head and neck FNA biopsy specimens. Cancer Cytopathol. 2022 07; 130(7):523-530.
    View in: PubMed
    Score: 0.071
  38. Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration. Mod Pathol. 2022 08; 35(8):1045-1054.
    View in: PubMed
    Score: 0.071
  39. Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers. Cancer. 2021 05 15; 127(10):1699-1711.
    View in: PubMed
    Score: 0.066
  40. National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System. Head Neck. 2021 01; 43(1):108-115.
    View in: PubMed
    Score: 0.064
  41. Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration. Br J Cancer. 2020 10; 123(9):1456-1463.
    View in: PubMed
    Score: 0.064
  42. Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomes. Head Neck. 2020 11; 42(11):3326-3335.
    View in: PubMed
    Score: 0.064
  43. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
    View in: PubMed
    Score: 0.063
  44. Risk Prediction Models for Head and Neck Cancer in the US Population From the INHANCE Consortium. Am J Epidemiol. 2020 04 02; 189(4):330-342.
    View in: PubMed
    Score: 0.062
  45. Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model. Cancer. 2020 02 15; 126(4):749-756.
    View in: PubMed
    Score: 0.061
  46. Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE). Cancer Epidemiol. 2019 12; 63:101615.
    View in: PubMed
    Score: 0.060
  47. Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach. Oral Oncol. 2019 07; 94:47-57.
    View in: PubMed
    Score: 0.059
  48. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol. 2019 07 10; 37(20):1753-1774.
    View in: PubMed
    Score: 0.058
  49. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. 2019 06 01; 125(11):1823-1829.
    View in: PubMed
    Score: 0.058
  50. Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancers. Oral Oncol. 2018 10; 85:103-105.
    View in: PubMed
    Score: 0.056
  51. Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium. Cancer Causes Control. 2018 Jul; 29(7):619-630.
    View in: PubMed
    Score: 0.055
  52. Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck. Mol Carcinog. 2018 06; 57(6):784-793.
    View in: PubMed
    Score: 0.054
  53. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy. Cancer. 2018 04 01; 124(7):1415-1427.
    View in: PubMed
    Score: 0.054
  54. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol. 2018 01; 126(1):75-80.
    View in: PubMed
    Score: 0.053
  55. Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma. Carcinogenesis. 2017 10 01; 38(10):986-993.
    View in: PubMed
    Score: 0.052
  56. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck. 2017 10; 39(10):2079-2087.
    View in: PubMed
    Score: 0.052
  57. Reduced mRNA expression of nucleotide excision repair genes in lymphocytes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2017 05 01; 38(5):504-510.
    View in: PubMed
    Score: 0.051
  58. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx. Sci Rep. 2017 01 03; 7:39765.
    View in: PubMed
    Score: 0.050
  59. Apoptotic capacity and risk of squamous cell carcinoma of the head and neck. Eur J Cancer. 2017 02; 72:166-176.
    View in: PubMed
    Score: 0.050
  60. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy. Oncotarget. 2016 Jun 07; 7(23):35015-25.
    View in: PubMed
    Score: 0.048
  61. Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx. Oncotarget. 2016 May 03; 7(18):26444-53.
    View in: PubMed
    Score: 0.048
  62. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma. Head Neck. 2016 08; 38(8):1139-44.
    View in: PubMed
    Score: 0.047
  63. Reduced DNA double-strand break repair capacity and risk of squamous cell carcinoma of the head and neck--A case-control study. DNA Repair (Amst). 2016 Apr; 40:18-26.
    View in: PubMed
    Score: 0.047
  64. Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. BMC Cancer. 2016 Feb 08; 16:70.
    View in: PubMed
    Score: 0.047
  65. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck. Tumour Biol. 2016 Jun; 37(6):8057-66.
    View in: PubMed
    Score: 0.046
  66. Improving patient outcomes through multidisciplinary treatment planning conference. Head Neck. 2016 04; 38 Suppl 1:E1820-5.
    View in: PubMed
    Score: 0.046
  67. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma. Cancer. 2016 Feb 15; 122(4):534-45.
    View in: PubMed
    Score: 0.046
  68. Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis. Int J Epidemiol. 2016 06; 45(3):835-45.
    View in: PubMed
    Score: 0.045
  69. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer. Eur J Cancer. 2015 Jul; 51(11):1415-23.
    View in: PubMed
    Score: 0.044
  70. Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. Int J Epidemiol. 2015 Feb; 44(1):169-85.
    View in: PubMed
    Score: 0.044
  71. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer. 2015 Mar 01; 136(5):1125-39.
    View in: PubMed
    Score: 0.042
  72. Genetic susceptibility to head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2014 May 01; 89(1):38-48.
    View in: PubMed
    Score: 0.041
  73. TNF-a promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx. Int J Cancer. 2014 Oct 01; 135(7):1615-24.
    View in: PubMed
    Score: 0.041
  74. Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):160-71.
    View in: PubMed
    Score: 0.040
  75. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma. Cancer Cytopathol. 2014 Feb; 122(2):96-103.
    View in: PubMed
    Score: 0.040
  76. Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck. Eur J Cancer. 2014 Feb; 50(3):582-92.
    View in: PubMed
    Score: 0.040
  77. Clinical characteristics of patients with multiple potentially human papillomavirus-related malignancies. Head Neck. 2014 Jun; 36(6):819-25.
    View in: PubMed
    Score: 0.040
  78. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol. 2013 Sep 01; 178(5):679-90.
    View in: PubMed
    Score: 0.039
  79. Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites. J Cell Mol Med. 2013 Jul; 17(7):873-8.
    View in: PubMed
    Score: 0.039
  80. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck. Carcinogenesis. 2013 Jul; 34(7):1551-7.
    View in: PubMed
    Score: 0.038
  81. Correspondence re: Zheng et al, Haplotype of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. 11: 640-645, 2002. Cancer Epidemiol Biomarkers Prev. 2003 Jan; 12(1):71; author reply 72.
    View in: PubMed
    Score: 0.038
  82. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer. FASEB J. 2013 Apr; 27(4):1404-12.
    View in: PubMed
    Score: 0.038
  83. Functional repeats (TGYCC)n in the p53-inducible gene 3 (PIG3) promoter and susceptibility to squamous cell carcinoma of the head and neck. Carcinogenesis. 2013 Apr; 34(4):812-7.
    View in: PubMed
    Score: 0.038
  84. Reconstructive outcomes in patients with head and neck sarcoma. Head Neck. 2013 May; 35(5):677-83.
    View in: PubMed
    Score: 0.036
  85. Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck. BMC Cancer. 2012 May 01; 12:159.
    View in: PubMed
    Score: 0.036
  86. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck. Mol Cancer. 2012 Mar 26; 11:17.
    View in: PubMed
    Score: 0.036
  87. Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck. Mol Carcinog. 2012 Oct; 51 Suppl 1:E132-41.
    View in: PubMed
    Score: 0.036
  88. Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics. 2012 Jan; 22(1):50-7.
    View in: PubMed
    Score: 0.035
  89. Genetic variants of a BH3-only pro-apoptotic gene, PUMA, and risk of HPV16-associated squamous cell carcinoma of the head and neck. Mol Carcinog. 2012 Oct; 51 Suppl 1:E54-64.
    View in: PubMed
    Score: 0.035
  90. Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2642-5.
    View in: PubMed
    Score: 0.035
  91. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2011 Nov; 32(11):1668-74.
    View in: PubMed
    Score: 0.035
  92. Radiation-associated head and neck sarcomas: spectrum of imaging findings. Oral Oncol. 2012 Feb; 48(2):155-61.
    View in: PubMed
    Score: 0.035
  93. Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res. 2011 Dec 01; 17(23):7248-64.
    View in: PubMed
    Score: 0.034
  94. Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics. 2011 Jul; 21(7):388-96.
    View in: PubMed
    Score: 0.034
  95. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck. Cancer. 2012 Jan 15; 118(2):485-92.
    View in: PubMed
    Score: 0.034
  96. Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck. BMC Cancer. 2011 Jun 20; 11:258.
    View in: PubMed
    Score: 0.034
  97. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck. Mol Carcinog. 2011 Sep; 50(9):697-706.
    View in: PubMed
    Score: 0.034
  98. Pediatric sarcomas and related tumors of the head and neck. Cancer Treat Rev. 2011 Oct; 37(6):431-9.
    View in: PubMed
    Score: 0.034
  99. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet. 2011 Mar; 7(3):e1001333.
    View in: PubMed
    Score: 0.033
  100. DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. Clin Cancer Res. 2011 Apr 01; 17(7):2035-43.
    View in: PubMed
    Score: 0.033
  101. A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers. Cancer Epidemiol Biomarkers Prev. 2011 Apr; 20(4):658-64.
    View in: PubMed
    Score: 0.033
  102. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer. 2010 Oct 15; 116(20):4753-60.
    View in: PubMed
    Score: 0.032
  103. Association between a functional polymorphism (-1195T>C) in the IGFBP5 promoter and head and neck cancer risk. Head Neck. 2011 May; 33(5):650-60.
    View in: PubMed
    Score: 0.032
  104. A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2010 Dec; 31(12):2082-90.
    View in: PubMed
    Score: 0.032
  105. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2010 Nov; 31(11):1977-81.
    View in: PubMed
    Score: 0.032
  106. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck. 2011 Jun; 33(6):847-55.
    View in: PubMed
    Score: 0.032
  107. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2010 Jun; 19(6):1484-91.
    View in: PubMed
    Score: 0.031
  108. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer. 2010 May 15; 116(10):2350-9.
    View in: PubMed
    Score: 0.031
  109. Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. DNA Repair (Amst). 2010 May 04; 9(5):558-66.
    View in: PubMed
    Score: 0.031
  110. Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol. 2010 Aug; 39(4):1091-102.
    View in: PubMed
    Score: 0.031
  111. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila). 2010 Feb; 3(2):246-53.
    View in: PubMed
    Score: 0.031
  112. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
    View in: PubMed
    Score: 0.031
  113. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis. 2010 Feb; 31(2):222-7.
    View in: PubMed
    Score: 0.030
  114. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. Int J Cancer. 2009 Dec 01; 125(11):2660-5.
    View in: PubMed
    Score: 0.030
  115. Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck. Carcinogenesis. 2009 Dec; 30(12):2053-8.
    View in: PubMed
    Score: 0.030
  116. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol. 2010 Feb; 39(1):182-96.
    View in: PubMed
    Score: 0.030
  117. Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol. 2009 Oct 15; 170(8):937-47.
    View in: PubMed
    Score: 0.030
  118. A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis. 2009 Oct; 30(10):1717-21.
    View in: PubMed
    Score: 0.030
  119. Marijuana smoking and the risk of head and neck cancer: pooled analysis in the INHANCE consortium. Cancer Epidemiol Biomarkers Prev. 2009 May; 18(5):1544-51.
    View in: PubMed
    Score: 0.029
  120. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila). 2009 May; 2(5):432-9.
    View in: PubMed
    Score: 0.029
  121. Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites. Cancer. 2009 Apr 15; 115(8):1660-8.
    View in: PubMed
    Score: 0.029
  122. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis. 2009 Jun; 30(6):997-1002.
    View in: PubMed
    Score: 0.029
  123. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009 May 20; 27(15):2509-15.
    View in: PubMed
    Score: 0.029
  124. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Feb; 18(2):541-50.
    View in: PubMed
    Score: 0.029
  125. Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer. 2009 Jan 15; 124(2):394-401.
    View in: PubMed
    Score: 0.029
  126. Type of alcoholic beverage and risk of head and neck cancer--a pooled analysis within the INHANCE Consortium. Am J Epidemiol. 2009 Jan 15; 169(2):132-42.
    View in: PubMed
    Score: 0.028
  127. CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008 Oct 01; 14(19):6343-9.
    View in: PubMed
    Score: 0.028
  128. Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):1974-81.
    View in: PubMed
    Score: 0.028
  129. Chromosome instability and risk of squamous cell carcinomas of head and neck. Cancer Res. 2008 Jun 01; 68(11):4479-85.
    View in: PubMed
    Score: 0.027
  130. Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2008 Sep 08; 268(1):158-65.
    View in: PubMed
    Score: 0.027
  131. In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck. Int J Cancer. 2007 Dec 15; 121(12):2735-40.
    View in: PubMed
    Score: 0.027
  132. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer. 2007 Aug 15; 110(4):867-75.
    View in: PubMed
    Score: 0.026
  133. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2007 Sep; 28(9):2008-12.
    View in: PubMed
    Score: 0.026
  134. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1633-8.
    View in: PubMed
    Score: 0.026
  135. Polymorphic TP53BP1 and TP53 gene interactions associated with risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2007 Jul 15; 13(14):4300-5.
    View in: PubMed
    Score: 0.026
  136. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. Cancer Res. 2007 Jun 15; 67(12):5628-34.
    View in: PubMed
    Score: 0.026
  137. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007 May 16; 99(10):777-89.
    View in: PubMed
    Score: 0.026
  138. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis. 2007 May; 28(5):988-94.
    View in: PubMed
    Score: 0.025
  139. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602.
    View in: PubMed
    Score: 0.024
  140. Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):557-64.
    View in: PubMed
    Score: 0.023
  141. Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev. 2005 Aug; 14(8):1961-6.
    View in: PubMed
    Score: 0.023
  142. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2005 May 20; 115(1):131-6.
    View in: PubMed
    Score: 0.022
  143. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005 Sep; 26(9):1596-602.
    View in: PubMed
    Score: 0.022
  144. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1188-93.
    View in: PubMed
    Score: 0.022
  145. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):1034-6.
    View in: PubMed
    Score: 0.022
  146. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics. 2005 Mar; 15(3):159-65.
    View in: PubMed
    Score: 0.022
  147. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004 Dec 01; 10(23):7903-10.
    View in: PubMed
    Score: 0.022
  148. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol. 2004 Oct; 28(10):1299-310.
    View in: PubMed
    Score: 0.021
  149. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3996-4002.
    View in: PubMed
    Score: 0.021
  150. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
    View in: PubMed
    Score: 0.021
  151. No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1081-3.
    View in: PubMed
    Score: 0.021
  152. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol. 2004 Jan 01; 159(1):1-16.
    View in: PubMed
    Score: 0.020
  153. Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas. Am J Surg Pathol. 2003 Sep; 27(9):1216-20.
    View in: PubMed
    Score: 0.020
  154. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):640-5.
    View in: PubMed
    Score: 0.018
  155. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2002 Jun 20; 99(6):869-72.
    View in: PubMed
    Score: 0.018
  156. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002 Jan 15; 94(2):393-7.
    View in: PubMed
    Score: 0.018
  157. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Cancer. 2019 05 01; 125(9):1536-1546.
    View in: PubMed
    Score: 0.014
  158. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma. Int J Cancer. 2017 Feb 01; 140(3):504-512.
    View in: PubMed
    Score: 0.012
  159. p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck. Head Neck. 2013 Nov; 35(11):1527-33.
    View in: PubMed
    Score: 0.009
  160. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2012 Jun; 97(6):1913-21.
    View in: PubMed
    Score: 0.009
  161. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Cancer. 2011 Mar 15; 117(6):1227-35.
    View in: PubMed
    Score: 0.008
  162. The functional IGFBP7 promoter -418G>A polymorphism and risk of head and neck cancer. Mutat Res. 2010 Sep 30; 702(1):32-9.
    View in: PubMed
    Score: 0.008
  163. A single nucleotide polymorphism in the alcohol dehydrogenase 7 gene (alanine to glycine substitution at amino acid 92) is associated with the risk of squamous cell carcinoma of the head and neck. Cancer. 2010 Jun 15; 116(12):2984-92.
    View in: PubMed
    Score: 0.008
  164. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis. 2008 Apr; 29(4):875-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.